Your browser doesn't support javascript.
loading
Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.
Wongjarupong, Nicha; Yonli, Albert Theophane; Nagalo, Bolni Marius; Djigma, Florencia Wendkuuni; Somda, Sosthene Kounpielime; Hassan, Mohamed A; Mohamed, Essa A; Sorgho, Abel Pegdwende; Compaore, Tegwinde Rebeca; Soubeiga, Serge Theophile; Kiendrebeogo, Isabelle; Sanou, Mahamoudou; Diarra, Birama; Yang, Hwai-I; Chen, Chien-Jen; Ouattara, Abdoul K; Zohoncon, Théodora M; Martinson, Jeremy J; Buetow, Kenneth; Chamcheu, Jean Christopher; Antwi, Samuel O; Borad, Mitesh J; Simpore, Jacques; Roberts, Lewis R.
Afiliação
  • Wongjarupong N; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
  • Yonli AT; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Nagalo BM; Division of Hematology and Medical Oncology Mayo Clinic Hospital Phoenix AZ.
  • Djigma FW; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Somda SK; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Hassan MA; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
  • Mohamed EA; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
  • Sorgho AP; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Compaore TR; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Soubeiga ST; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Kiendrebeogo I; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Sanou M; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Diarra B; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Yang HI; Genomics Research Center Academia Sinica Taipei Taiwan.
  • Chen CJ; Genomics Research Center Academia Sinica Taipei Taiwan.
  • Ouattara AK; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Zohoncon TM; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Martinson JJ; Division of Infectious Diseases and Microbiology University of Pittsburgh Pittsburgh PA.
  • Buetow K; Computational Sciences and Informatics Program for Complex Adaptive System Arizona State University Tempe AZ.
  • Chamcheu JC; College of Pharmacy University of Louisiana Monroe Monroe LA.
  • Antwi SO; Department of Health Sciences Research Mayo Clinic Jacksonville FL.
  • Borad MJ; Division of Hematology and Medical Oncology Mayo Clinic Hospital Phoenix AZ.
  • Simpore J; Department of Biochemistry and Microbiology Pietro Annigonni Biomolecular Research Center Ouagadougou Burkina Faso West Africa.
  • Roberts LR; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
Hepatol Commun ; 4(12): 1781-1792, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33305149
Hepatitis B virus (HBV) genotype E (HBV-E) accounts for the majority of chronic hepatitis B (CHB) infections in West Africa. We aimed to determine factors associated with HBV-E-induced hepatocellular carcinoma (HCC) in West Africa. Data on patients from Burkina Faso who were hepatitis B surface antigen positive (HBsAg+) and had CHB were analyzed. HBV viral load and hepatitis B e antigen (HBeAg) status were measured in 3,885 individuals with CHB without HCC (CHB HCC-) and 59 individuals with CHB with HCC (CHB HCC+). HBV genotyping was performed for 364 subjects with CHB HCC- and 41 subjects with CHB HCC+. Overall, 2.5% of the CHB HCC- group was HBeAg+ compared with 0% of the CHB HCC+ group. Of the 364 patients who were CHB HCC- with available genotyping, the frequencies of HBV genotypes E and C/E were 70.3% and 12.9%, respectively. Age (odds ratio [OR] for older age, 1.08; 95% confidence interval [CI], 1.06-1.10 per 1-year increase in age), male sex (OR, 2.03; 95% CI, 1.11-3.69), and HBV viremia (OR, 1.48; 95% CI, 1.31-1.67 per 1 log10 IU/mL) were each associated with HCC diagnosis. Patients with genotype E had a lower HBeAg prevalence (6.3% vs. 14.9%), lower HBV viral load, and higher prevalence of cirrhosis (14.5% vs. 4.8%) than patients with genotype C/E. Conclusion: HBV-E is the most common circulating strain (70.3%) in West African patients. HCC was associated with older age, male sex, and high HBV viral load. It is expected that these results will further inform guidance on clinical management of HBV infection in West Africa.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: Hepatol Commun Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: Hepatol Commun Ano de publicação: 2020 Tipo de documento: Article